tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
PremiumWeekend UpdatesAvidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
28d ago
Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls
Premium
The Fly
Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls
1M ago
Alkermes upgraded to Buy from Neutral at UBS
Premium
The Fly
Alkermes upgraded to Buy from Neutral at UBS
1M ago
Alkermes has near-term catalyst with narcolepsy data, says H.C. Wainwright
PremiumThe FlyAlkermes has near-term catalyst with narcolepsy data, says H.C. Wainwright
3M ago
Alkermes price target raised to $41 from $38 at Baird
Premium
The Fly
Alkermes price target raised to $41 from $38 at Baird
3M ago
Alkermes Hold Rating: Balancing Orexin Program Prospects and Competitive Risks
Premium
Ratings
Alkermes Hold Rating: Balancing Orexin Program Prospects and Competitive Risks
3M ago
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Alkermes price target lowered to $33 from $38 at UBS
Premium
The Fly
Alkermes price target lowered to $33 from $38 at UBS
3M ago
Balanced Assessment of Alkermes: Hold Rating Justified by Stable Valuation and Orexin Program Potential
Premium
Ratings
Balanced Assessment of Alkermes: Hold Rating Justified by Stable Valuation and Orexin Program Potential
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100